Boston Research & Management Inc. Lowers Stake in Xylem Inc. (NYSE:XYL)

Boston Research & Management Inc. trimmed its holdings in shares of Xylem Inc. (NYSE:XYL) by 0.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 62,642 shares of the industrial products company’s stock after selling 475 shares during the quarter. Xylem comprises about 2.3% of Boston Research & Management Inc.’s holdings, making the stock its 7th largest position. Boston Research & Management Inc.’s holdings in Xylem were worth $7,747,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Moors & Cabot Inc. raised its position in shares of Xylem by 309.6% in the 3rd quarter. Moors & Cabot Inc. now owns 28,000 shares of the industrial products company’s stock worth $28,000 after acquiring an additional 21,164 shares in the last quarter. Compagnie Lombard Odier SCmA bought a new position in Xylem in the 3rd quarter worth $74,000. SouthState Corp bought a new stake in Xylem during the third quarter valued at about $74,000. First Horizon Advisors Inc. grew its position in shares of Xylem by 82.0% during the third quarter. First Horizon Advisors Inc. now owns 808 shares of the industrial products company’s stock valued at $78,000 after purchasing an additional 364 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC grew its position in Xylem by 49.2% in the second quarter. O Shaughnessy Asset Management LLC now owns 795 shares of the industrial products company’s stock worth $95,000 after acquiring an additional 262 shares in the last quarter. Hedge funds and other institutional investors own 83.84% of the company’s stock.

In other Xylem news, CEO Patrick Decker sold 54,643 shares of Xylem stock in a transaction that occurred on Tuesday, November 9th. The stock was sold at an average price of $132.91, for a total value of $7,262,601.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Matthew Francis Pine sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, November 5th. The shares were sold at an average price of $130.49, for a total value of $260,980.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 64,238 shares of company stock worth $8,470,296. Insiders own 0.90% of the company’s stock.

A number of brokerages have recently issued reports on XYL. Rosenblatt Securities downgraded Xylem from a “buy” rating to a “hold” rating and reduced their price target for the stock from $140.00 to $120.00 in a research report on Friday, October 1st. Royal Bank of Canada dropped their price target on shares of Xylem from $140.00 to $136.00 and set an “outperform” rating for the company in a research note on Friday, October 1st. Raymond James cut shares of Xylem from a “market perform” rating to an “underperform” rating in a research report on Tuesday, January 4th. Mizuho began coverage on shares of Xylem in a report on Thursday, December 16th. They issued a “neutral” rating and a $115.00 price objective on the stock. Finally, Credit Suisse Group raised their price objective on shares of Xylem from $105.00 to $111.00 and gave the stock an “underperform” rating in a research report on Wednesday, November 3rd. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $122.30.

Shares of NYSE XYL traded down $3.38 during midday trading on Friday, reaching $111.04. 41,525 shares of the company traded hands, compared to its average volume of 913,558. The stock’s 50-day simple moving average is $122.02 and its 200-day simple moving average is $125.57. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.81 and a current ratio of 2.33. Xylem Inc. has a 12 month low of $94.63 and a 12 month high of $138.78. The firm has a market cap of $20.02 billion, a PE ratio of 44.87, a PEG ratio of 3.26 and a beta of 1.03.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, November 2nd. The industrial products company reported $0.63 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.59 by $0.04. Xylem had a return on equity of 15.97% and a net margin of 8.81%. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.28 billion. During the same period in the previous year, the company earned $0.62 EPS. On average, equities research analysts expect that Xylem Inc. will post 2.48 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 21st. Shareholders of record on Tuesday, November 23rd were issued a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date of this dividend was Monday, November 22nd. Xylem’s dividend payout ratio is 43.92%.

Xylem Company Profile

Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.

Further Reading: Shanghai Stock Exchange Composite Index

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.